Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Vascular Occlusion and Rheumatoid Arthritis

This study is currently recruiting participants. (see Contacts and Locations)
Verified February 2014 by University of Sao Paulo
Sponsor:
Information provided by (Responsible Party):
Bruno Gualano, University of Sao Paulo
ClinicalTrials.gov Identifier:
NCT01483157
First received: November 29, 2011
Last updated: February 27, 2014
Last verified: February 2014

November 29, 2011
February 27, 2014
November 2011
November 2015   (final data collection date for primary outcome measure)
muscle strength [ Time Frame: twelve weeks ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT01483157 on ClinicalTrials.gov Archive Site
quality of life [ Time Frame: twelve weeks ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
Vascular Occlusion and Rheumatoid Arthritis
Effects of Strength Training With Vascular Occlusion in Patients With Rheumatoid Arthritis: A Randomized Clinical Trial

Resistance exercise plus vascular occlusion may induce greater improvements in strength and muscle mass resistance training alone. The investigators speculate this training strategy could be beneficial in patients with rheumatoid arthritis.

Not Provided
Interventional
Not Provided
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Rheumatoid Arthritis
  • Other: vascular occlusion with exercise trainig
    twelve weeks of resistance training with vascular occlusion twice a week
  • Other: high intensity resistance training
    twelve weeks of resistance training twice a week
  • Experimental: low intensity with vascular occlusion
    Intervention: Other: vascular occlusion with exercise trainig
  • Experimental: high intensity resistance training
    Intervention: Other: high intensity resistance training
  • No Intervention: no exercise training
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
30
November 2015
November 2015   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • female with rheumatoid arthritis
  • Disease activity scores > 2.6
  • use of anti-TNF-alpha drugs for at least 8 weeks

Exclusion Criteria:

  • BMD < 20 kg/m2
  • fibromyalgia
  • cardiovascular disease
Female
30 Years to 70 Years
No
Brazil
 
NCT01483157
vascular occlusion and RA
No
Bruno Gualano, University of Sao Paulo
University of Sao Paulo
Not Provided
Not Provided
University of Sao Paulo
February 2014

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP